Cystic echinococcosis is endemic in the Rio Negro province of Argentina. After 30 years of control using praziquantel in dogs the transmission rate to humans and sheep has decreased significantly, however transmission persists. The objective of the study is to assess the impact of the inclusion of the EG95 vaccine for sheep in the control program, including analysis of the vaccine's operative feasibility in field conditions. The vaccine was applied in an area comprising four communities of native people including 79 farms with 3146 lambs and 311 dogs in total. Seventy one farms were designated as control areas where no vaccinations were undertaken while vaccinations of lambs undertaken on 91 farms. Lambs received two vaccinations with the EG95 vaccine followed by a single booster injection when the animals were 1-1.5 years of age. Farm locations were defined using GPS coordinates for the houses. Evidence for Echinococcus granulosus transmission was monitored by coproantigen ELISA on samples of dog faeces, by E. granulosus-specific PCR using soil samples, and anti-E. granulosus antibody assessments in sera from 2-4 teeth lambs, purgation of dogs to detect E. granulosus worms and necropsy on adult sheep. Before the vaccine was introduced, 26.2% of sheep with 2-4 teeth were positive using ELISA/WB, the prevalence decreased to 7.8% at the third year following use of the vaccine. Necropsy of animals older than 6 years (not vaccinated) showed that 66.1% of animals were infected with E. granulosus. In dogs, 4% was found positive for E. granulosus using arecoline purgation and 24.7% of the farms were infected using coproELISA/WB. During the first year of vaccination 2721 lambs received the first vaccine dose and 2448 received a booster. In the second year 2138 lambs were initially vaccinated and 1745 received a booster, and 1308 animals received the third dose. During the third year 1110 lambs received the first dose from which 539 received a booster and 723 animals received the third dose. An analysis of advantages and limitations of the diagnostic techniques used and the ability of the geospatial analysis to detect risk area are included. Based in the immunodiagnostic techniques, the EG95 vaccine has been able to prevent the infection in animals up to 3 years old. Also, the difficulties in the field for the correct vaccine administration and the social features and habits that may impact on echinococcosis control are included in the analysis.
Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary data Edmundo Larrieu a,b 
Introduction
Cystic echinococcosis (CE) is a parasitic zoonosis caused by infection with a taeniid cestode parasite, Echinococcus granulosus. The parasite requires two mammalian hosts to complete its life cycle. In South America the most important definitive host is the dog (which develops the adult tapeworm stage) and the most common intermediate host is the sheep (which develops the larval stage). Goats, pigs and cattle can be involved also as intermediate hosts (Eckert et al., 2001; Larrieu and Zanini, 2012) . CE is one of the most prevalent zoonoses in Argentina, causing a significant burden for the health system due to the high costs of surgery and days spent in hospitals. It also causes losses in livestock due to the condemnation of infected viscera and decreases in production of wool, milk and meat (Budke et al., 2006) . (Eckert et al., 2001 ).
However, where CE control has relied on frequent treatment of dogs with praziquantel, more than 10 years of intensive, compulsory intervention has been required before CE transmission reached a low level and almost 30 years has been required to achieve freedom from the disease (Craig and Larrieu, 2006) . In other areas where CE control activities have been undertaken in the past century, the infrastructure required to treat the dogs 8 to 12 times per year for a long period of time (10 years or more) has not been sustainable, often because CE endemic areas are the poorest in each endemic country (Larrieu and Zanini, 2012) .
A control program for CE started in 1980 in the Rio Negro Province based on treatment of dogs with praziquantel every 90 days, using the existing primary health care infrastructure to deworm dogs. A group of health care assistants (non-professional staff) conducted home visits, while veterinarians from the health department lent support and managed the surveillance system. This network carried out four rounds of Page 4 of 27 A c c e p t e d M a n u s c r i p t 4 home visits annually. The health care assistants visited rural areas distributing praziquantel tablets to dog owners who were ultimately responsible for carrying out the deworming. Education activities were also undertaken in the community concerning the nature of the disease, lifecycle and the need to prevent dogs gaining access to sheep offal. Serological testing and untrasonography were undertaken on the human population in order to effect early diagnosis of CE infections (Larrieu et al., 2000; Larrieu et al., 2011; Larrieu and Zanini, 2012) . The program has been successful in decreasing the prevalence of E. granulosus in dogs and humans, although a proportion of infected sheep remain and this has been sufficient to lead to a continued incidence of CE in children (Larrieu et al., 2001; Larrieu et al., 2000) .
Vaccination of potential intermediate hosts of E. granulosus with the EG95
recombinant vaccine Lightowlers et al., 1996) could potentially be used to reduce the level of E. granulosus transmission and decrease the incidence of human infections (Bethony et al., 2011) . Torgerson (2003 Torgerson ( , 2006 and Torgerson and Heath (2003) have used mathematical models to predict the impact of various options for control of CE and considered that a program involving vaccination of intermediate hosts together with 6-monthly treatment of dogs with praziquantel would decrease the time needed to achieve control of disease transmission.
The EG95 vaccine is a recombinant protein cloned from mRNA from the oncosphere life cycle stage of the parasite. The vaccine comprises the EG95 protein together with the adjuvant Quil A. Two immunizations in young animals protects against a challenge infection with E. granulosus by inducing specific antibodies against the oncosphere, eliminating it before it can establish and develop in the tissues of the intermediate host. EG95 is a defined protein, non infectious, non toxic and is produced using genetic engineering and expressed in Escherichia coli Lightowlers et al., 1999; Lightowlers et al., 1996) . However, other than some data about the use of the vaccine in China (Heath et al., 2006; Heath et al., 2003) , there is little published information about the impact of the EG95 vaccine when used in field conditions nor about potential problems that could arise when the vaccine was applied on a large scale in livestock flocks (Larrieu and Zanini, 2012) .
In order to assess the impact of the introduction of the EG95 vaccine in the control program in Rio Negro, the authorities in charge of the program decided to trial the introduction of the vaccine as an additional control tool. It is considered that optimal protection with the EG95 vaccine would be afforded by two immunizations in lambs M a n u s c r i p t 5 followed by annual booster immunizations . However the resources available for hydatid control in Rio Negro were insufficient to support the requirements of this regime and it was decided to undertake a vaccination program in which lambs received two vaccinations followed by a single booster immunization when the animals were 1-1.5 years of age. The objective of this work was as assessment of the baseline data in the regions selected for the control programme with vaccination and a preliminary assessment of the effects of EG95 vaccination on lambs born following the introduction of the vaccine. Secondary objectives include the assessment of the advantages and disadvantages of the diagnostic tests available for epidemiological surveillance of CE and also an analysis of the usefulness of the geospatial analysis in the CE control activities.
Materials and Methods

Work Area
The regions chosen for the program were Anecon Grande, Rio Chico Abajo, 
Initial diagnostics before introduction of EG95 in the control programme:
Two meetings were held with the communities and their higher authority Methods used were: coproELISA used as screening and confirmed with Western Blot in dog faeces (Cavagion et al., 2005; Guarnera et al., 2000) . ELISA as screening and confirmation with Western Blot in sheep sera (Gatti et al., 2007) ; PCR was used for soil samples from each EU (Cabrera et al., 2002) for the detection of E. granulosus contamination. Direct methods used were necropsy of sheep with histological confirmation (Cabrera et al., 2003) and arecoline purgation in dogs (Perez et al., 2006) .
EU selected for the baseline survey were selected at random. The size of the sample (''n'': 109 farms) was determined with the following parameters: 95% confidence level and 20% error margin. The arecoline purgation test was applied in dogs brought by the owners (not randomized).
CoproELISA/WB: fresh faeces were collected directly from the ground from each EU. One sample was collected for every 2 dogs. They were collected in plastic containers without fixatives and sent to the Laboratory for Environmental Health (San Carlos de Bariloche) to be tested by copro/ELISA. The samples that tested positive were sent for confirmation by WB to the National Institute of Microbiology (ANLIS/MALBRAN) following procedures previously described (Guarnera et al., 2000) . The presence of one positive sample classified the EU as infected.
With this variable ("dog faeces coproELISA/WB positive-negative") cluster and atypical value (Anselin and Morans I) was estimated. The buffer tool was applied for determining spatial relation between negative EU that are in the influence's zone of a positive EU at within a distance of 2 kilometres (maximum area exposed to infected dogs) ELISA/WB: 10 ml of blood from jugular puncture were obtained from lambs with 2-4 teeth. Samples were centrifuged to obtain sera and kept at 5°C before they were sent to the Laboratory of Zoonoses, Viedma, Rio Negro where the samples were kept at -20°C. ELISA was performed as previously described (Gatti et al., 2007) .
PCR: soil samples (300g per house) were taken in each EU from areas near where the dogs sheltered. Soil was deposited in plastic bags and processed at the National Institute of Microbiology (ANLIS-MALBRAN) following procedures previously described (Cabrera et al., 2002) . M a n u s c r i p t 7 Necropsy: animals > 6 years old were purchased from farmers and euthanized at the local slaughterhouse in Ingeniero Jacobacci; the slaughterhouse was used exclusively for trial purposes on the days that these animals were analysed. The presence of at least one viable CE cyst classified the animal as positive. Calcified and contaminated cysts were collected for histological confirmation.
Dogs concentration by arecoline purgation was carried out in each of the 5 works area and the purge examined for the presence of E. granulosus using a tray with a dark surface (Perez et al., 2006) .
Vaccination and other CE control activities
Four teams were charged with vaccinating the sheep, each of them comprised 2 veterinarians from the Minister of Health and one sanitary agent from each community.
The EG95 vaccine used was produced by the University of Melbourne (Gauci et al., 2011) ; the vaccine was lyophilized and provided in vials containing 50 or 100 doses.
The vaccine was rehydrated with sterile distilled water on the morning of the day of use.
One ml of reconstituted vaccine containing 50µg EG95 and 1 mg Quil A was injected subcutaneously in the neck of the animal. Vaccine containers with vaccine already diluted were kept in coolers while travelling between the different EUs.
Two different groups were assigned to different treatment types. One group comprising 71 EU of Blancura Centro and Lipetren regions, was established as control EU where no vaccinations were undertaken. In the treatment group, comprising 79 EU of Anecón Grande, Mamuel Choique, Nahuel Pan and Rio Chico abajo regions, lambs received two initial immunizations with EG95 (the first dose was applied to animals at 30 days of age and the second dose at 60 days of age before weaning) and also received a booster immunization at approximately 1-1.5 years of age. Lambs born on these EU in subsequent years would undergo the same vaccination treatments until the end of the trial.
In one EU area in which vaccination was employed a different treatment type was required. In Nahuel Pan, 13 EU, rams are run permanently with the ewes such that there is not a clear breeding season when lambs are born. In this region the ewes were vaccinated with one dose of EG95 during the period December-January and also the lambs were vaccinated with the standard treatment. The objective of this treatment was to generate colostral immunity in lambs born after vaccination. 
Study of impact after vaccination
A preliminary study was carried out on sera from 2-4 teeth lambs during the third year following the initiation of the vaccination program using ELISA/WB serology. Results were compared with sera from animals of the same age from the control area.
Statistic and spatial analysis
Statistical comparisons between groups control and vaccination were performed using the Chi Square Test and statistical comparisons between different techniques were evaluated using the Fisher Exact Test (p value 0.05) and confidence intervals of 95% (CI95%) were estimating using EPIDAT 3.1 (Xunta of Galicia, Spain)
ArcGis 10.0 with the Spatial Analyst extension (ESRI) and SatScan 7.01 were used for geospatial analysis..
Results
Initial diagnostic in areas control and vaccination:
An initial census (2009) Table 2 . Statistical comparisons of the prevalences indicated in Table 2 In relation with the different techniques, the prevalence of CE in 2-4 teeth lambs was 25.7% determined using ELISA/WB whereas 61.3% of the animals older than 6 years were positive using the same test and 66.1% were positive at necropsy. No significant differences were found between the prevalence data obtained for aged sheep using the two methodologies (p>0.05).
The prevalence of E. granulosus infection determined in dogs using arecoline purgation was 4 %. Using Copro ELISA/WB on dog faeces, 11.2% of the samples were positive. Differences found between both tests were statistically significant (p<0.05). PCR in soil showed that 13.5% of the EU was infected and 24.7% of EU had 1 dog faeces positive. Difference in the results using copro/WB and PCR were no significant (p=0.05, but only 2 EU positives in copro/WB were also positives in PCR.
Spatial analysis in Rio
The average n of carcases was mean 13.6 +/-SD 2.2 kg. The infected animals were heavier (13.8+/-2.3) than the no infected animals (13.2+/-2.3), however the difference were not statistically significant (p>0.05).
Vaccination
Vaccination began in December 2009. The numbers of animals involved in the vaccinations during the 3 years in which the program has been continuing are shown in (Table 3) .
Study of impact
An initial assessment was made of the impact of the vaccine on infection levels found no significant differences with respect to all the measures of CE transmission that were assessed, excepted by PCR in soil (Table 2 ).
In the first year of the vaccination program 86.5% of the lambs born on the EU involved in the program received the first immunization and 77.8% of these received the second immunization, with approximately 94% of the EU participating in the program (Table 3 ). In the second year of the program a lower proportion of the animals that were Similarly, it is difficult to predict the level of immunity that may be induced in animals that do not receive each of these scheduled vaccinations. Heath et al. (2003) suggest that some degree of immunity to infection is stimulated by a single dose of EG95 in lambs. The animals were tagged such that it will be possible to differentiate animals born each year of the vaccination control programme however they were not numbered tags and it is not known which individual animals received vaccination.
Records are being maintained for each EU such that, where circumstances were such that one or more scheduled vaccinations did not take place for some reason (eg farmer unable to muster the animals), this information will be available for correlation with subsequent serology and necropsy data for these animals.
The control program for CE in Río Negro Province was developed by the Minister of Health in 1980 and was based mainly on dog treatment with anthelmintic drug. There were difficulties with implementation of the control program. Geographic isolation of the affected regions, adverse climatic conditions and the lack of vehicles adversely affected the program. These difficulties prevented some of the control areas being visited at some times of the year and this affected the coverage of dog treatments and other scheduled activities. However the control program proved to be successful since the prevalence in children (6 to 14 years old) decreased from 5.6% in 1986 (using ultrasonogrphy) to 0.3% in 2008 (Perez et al., 2006; Larrieu et al., 2011) . But new cases were also diagnosed each year in children. In sheep the prevalence decreased from 61% at the start of the program to less than 20% (Larrieu et al., 2011) , however it has remained around this percentage. Due to the persistence of the disease transmission, new control strategies were considered necessary, such as the vaccination of the animal intermediate hosts.
The diagnostic techniques used in this work to detect CE infection in sheep are generally not recommended (Eckert et al., 2001 ). However, some recent publications have found a good correlation between serology and necropsy examination for E.
granulosus infection (Dueger et al., 2003; Gatti et al., 2007) and for this reason, serology has been used in the work reported here.
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In relation to diagnosis of infection in dogs, the advantages and disadvantages of the arecoline purgation are well known. Advantages include it being 100% specific when worms are detected, and the test has value when the results can be demonstrated directly to dog owners so as to educate them about the parasite. However, the test has many disadvantages, including it being poorly sensitive, presenting some danger to the dogs and also being dangerous to the persons who have to handle infective purge material (Perez et al., 2006; Lahmar et al., 2007; Varcasia et al., 2011) . In comparison,
CoproELISA/WB is a simple, accurate and economic technique (Guarnera et al., 2000; Cavagion et al., 2005) . Its disadvantages are that the samples must be transported to a laboratory and hence the results cannot be immediately demonstrated to a dog owner. In this work, CoproELISA/WB was used as a tool for determination of environmental contamination (EU with at least 1 dog infected) and was not used for diagnosis of infection in individual animals. The procedure used for sampling dogs allowed the chance of taking samples from the same dog (Guarnera et al., 2000) .
PCR has been shown to be useful in the identification of E. granulosus from soil samples (Cabrera et al., 2002; Shaikenov et al., 2004; Mathis and Deplazes, 2006) . In this work PCR was used to assess the environmental contamination in the same way as coproELISA/WB, however the results were different using both techniques analysing samples from the same EU. The reasons for these differences are unclear. The samples analysed by the two methods were not the same and were taken at different times, with the samples assessed in PCR being obtained a year before those analysed by coproELISA/WB. It is unknown how long a farm that is found to be positive in PCR, due to contamination with E. granulosus, remains positive after the level of contamination decreases as measured by a reduction in the incidence of infection in
lambs.
An interesting finding was the similarity in weight of infected and non infected animals at necropsy. It has previously suggested that CE produces losses in meat production (Budke et al., 2006) . However the revision of literature does not allow identification of significant experiments done to verify this theory.
The use of geographic information systems (GIS) have become more common as a tool for public health investigations due to the increase in number and quality of satellites used for terrestrial observation. These systems integrate the use of GPS information, spatial analysis and communications and provide an improvement in epidemiological analysis and prediction of future events, using remote sensors for M a n u s c r i p t 13 monitoring of a particular disease producing information that is important in designing a control program.
GIS have been not been extensively used for non vector borne disease, even less for parasitic disease like CE. For E. multilocularis in Germany, a study by Staubasch et al. (2001) related the geographic location of positive faecal fox samples with water sources, soil humidity and type of vegetation in images captured by a satellite. While in China, temporal and spatial analysis have been performed using images captured by satellite analysing the kind of plants found and the location of villages using GPS in studies for prevalence of human CE (Graham et al., 2004) . Recently, Cringoli et al. Based on the immunodiagnostic techniques used in the present work, the EG95 vaccine has been able to prevent the infection in animals up to 3 years old. In the future it will be important to determine at necropsy if the vaccinated animals were protected by the vaccine during the animals' whole productive life. If this were the case, transmission to dogs would be prevented and therefore transmission of CE to humans would be eliminated.
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